7/26/2010

U.K. researchers will begin the first-ever clinical trial involving the use of bone marrow-extracted stem cells to extend survival of patients with dilated cardiomyopathy. The randomized study will recruit 90 patients and take place at the Barts and the London Heart Attack Center.

Related Summaries